The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of urolithin A supplementation, a mitophagy activator on mitochondrial health of immune cells (MitoIMMUNE): A randomized, double-blind, placebo-controlled trial in healthy adults.
 
Dominic Denk
Research Funding - Amazentis SA (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for using UA for cellular therapies
Travel, Accommodations, Expenses - Abbvie
 
Anurag Singh
Employment - Amazentis SA
Leadership - Amazentis SA
Stock and Other Ownership Interests - Amazentis SA
Patents, Royalties, Other Intellectual Property - Amazentis SA
 
Herbert Kasler
Research Funding - Amazentis SA (Inst); Lyfspn (Inst)
 
Lucia Alcober Boquet
No Relationships to Disclose
 
Davide D'Amico
Employment - Amazentis SA
Leadership - Amazentis SA
Stock and Other Ownership Interests - Amazentis SA
Patents, Royalties, Other Intellectual Property - Amazentis SA
 
Johanna Gorol
No Relationships to Disclose
 
Florian Greten
Consulting or Advisory Role - Amazentis SA
Research Funding - Amazentis SA (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending on the use of UA for cellular therapies